Abstract:Abstract Background Background: Inflammatory Bowel Disease (IBD) represents a multifaceted condition that can be characterised by the interplay of four primary elements: immunity, genetics, microbiome and environmental factors. Among these, the relationship between nutrition and the metabolome is pivotal and a number of machine learning based approaches have been developed in an effort to gain a better understanding of this relationship. Nevertheless, to date, these approaches suffer from interpretability, thereby restricting their practical applicability within clinical settings.Hence, in this study, we leverage two publicly available datasets, the UK Biobank (UKB) and the Human Microbiome Project Phase II IBD Multi’Omics Database (HMP2), to perform metabolomics-based IBD disease predictions. We apply explainable an AI (XAI) based framework to understand these predictions and explore the diet-metabolite relationships in IBD and non-IBD individuals. Methods 4,137 plasma samples (2,099 IBD, 2,038 non-IBD) from UKB and 546 fecal samples (411 IBD, 135 non-IBD) from HMP2 with complete dietary data were used in the analysis. Random forest classification, optimized by grid search and estimator retraining was then trained to predict disease with Shapley Additive exPlanations (SHAP) included downstream to generate further insight on the model’s predictions. Finally, diet-metabolite associations were examined using Spearman-based correlations. Results From the plasma dataset, inflammatory markers, HDL and LDL cholesterols and omega 3 fatty acids were identified in relationship with IBD diagnosis. Within the feces samples, the discriminatory metabolites identified included B vitamins, phospholipids, urobilin, and taurine, and these latter provided a better predictive power than the plasma derived biomarkers (AUC: fecal 0.90.(95% CI: 0.84-0.96), plasma 0.66 (95% CI: 0.61-0.71). Regarding diet contribution, fish, fruit, vegetables, and processed foods exhibited a strong correlation with metabolites in both datasets, with correlations in fecal samples exhibiting a stong difference between IBD and non-IBD patients. Conclusion While this study has certain limitations, these results suggest that, compared to healthy individuals, IBD patients are characterised by a distinct gut profile primarily influenced by diet. It also suggests that disease, or health, influences how the gut responds to food intake. Future studies should confirm these findings using XAI and analysing both gut and blood matrices in same individuals along with their dietary intake for personalized IBD therapy development.

EFFECT OF HIGH DOSES OF CORTISONE ON BONE MARROW CELL PROLIFERATION IN THE SYRIAN HAMSTER.

Artificial Intelligence Assists Surgeons’ Decision-Making of Temporary Ileostomy in Patients with Rectal Cancer Who Have Received Anterior Resection

Molecular dynamics of HIV-1 protease in complex with a difluoroketone-containing inhibitor: implications for the catalytic mechanism.

Performance of Machine Learning Algorithms for Predicting Disease Activity in Inflammatory Bowel Disease

Ultrastructural changes during formation and germination of microcysts in Polysphondylium pallidum, a cellular slime mould.

[Transperitoneal resorption of ampicillin, cefuroxim and gentamicin in continuous ambulatory peritoneal dialysis].

Low production “efficiency” of homoeotherm populations: a misunderstanding

Artificial intelligence in endoscopy related to inflammatory bowel disease: A systematic review

AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases: A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD

Machine Learning Prediction Model for Inflammatory Bowel Disease Based on Laboratory Markers. Working Model in a Discovery Cohort Study

Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications

P455 Deploying machine learning algorithms to stratify patients with inflammatory bowel disease using routinely collected electronic health records

Developing a Machine-Learning Prediction Model for Infliximab Response in Crohn’s Disease: Integrating Clinical Characteristics and Longitudinal Laboratory Trends

Applying Machine Learning Models Derived From Administrative Claims Data to Predict Medication Nonadherence in Patients Self-Administering Biologic Medications for Inflammatory Bowel Disease

Artificial intelligence and inflammatory bowel disease: Where are we going?

736 - Microbiota Metabolites Short-Chain Fatty Acids Inhibit TH1 Cell Induction of Colitis Through Promoting IL-10 Production Via GPR43

P429 Explainable AI identified metabolome and diet interactions in the blood and faceal samples

IIS Registry Grant Modelling Inflammatory Bowel Diseases trajectories combining dynamic, multifactorial, Artificial Intelligence-based approaches

Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data

Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol

High performance liquid chromatographic determination of nine phenolic antioxidants in oils, lards, and shortenings.